For some time, scientists have been aware of a therapeutic link between the drug Ketamine and depression. Research seemed to show that the use of this drug can rapidly reverse symptoms of major depression. Depression is a leading cause of Social Security disability.
Special K, Indeed?
The study of Ketamine has been hampered in part due to this anesthetic drug being used recreationally. Going by the nickname “Special K”, Ketamine has been long favored by those seeking a hallucinogenic experience. Needless to say, it is a powerful substance that can cause real harm.
FDA May Allow Doctors To Prescribe Ketamine
Despite the risks inherent in using Ketamine for therapeutic reasons, scientists have long wondered if the rumors about this drug alleviating depression have a basis in fact. Now, it appears, the Food and Drug Administration (FDA) is about the let doctors and their patients find out.
Johnson and Johnson took a big step toward getting their Ketamine-based drug, Esketamine, onto the market. An outside group of experts has recommended to the FDA that they approve Esketamine for treating depression.
A Depression Treatment That Works Rapidly
Esketemine is not a pill. Rather, it is a nasal spray. The doctors familiar with the drug are enthused about its potential to relieve depression. Among other things, Esketemine works very rapidly. Most treatments for depression takes weeks to show significant effects.
If approved, Johnson and Johnson will call the drug Spravato.
Ask Your Doctor About This Treatment
If you have depression that is resistant to most treatments, keep an eye on Spravato. If it reaches the market, ask your doctor about prescribing it for you. As always, never take any medication, especially one as potent as Ketamine, without medical supervision.
One Person’s Experience Using Ketamine For Depression
Here is a recent first-person account of using Ketamine to treat severe depression. It is very interesting reading.
UPDATE (March 6, 2019):
The FDA has approved Esketemine. Ask your doctor about it.
